Gastrointestinal procedures continue to dominate the ASC landscape in 2025, driven by increased screening demand, younger-onset colorectal cancer and ongoing migration of cases out of hospitals. All ...

A new study reveals India's drug-resistant infection rates are lower than those in the U.S. and Europe, despite microbial ...

As screening guidelines evolve and GI care increasingly shifts to outpatient settings, ASCs are seeing significant growth in colonoscopy volume. Here are ten developments shaping that trend: ...

The NCDC challenged a Lancet study on high MDRO colonisation in Indian ERCP patients, stating colonisation infection and ...

A low dose of colchicine — a commonly used gout drug — helped reduce the risk of heart attack and stroke in people with ...

Worldwide, colorectal cancer is the second leading cause of cancer-related mortality and the third most common cancer, with incidence rates increasing among individuals younger than 50 years.1 ...

Cancer surgery among patients older than 65 years is complex with high morbidity underscoring the need for specialized care at high-quality hospitals.

They have to undergo mandatory training on proper claiming practices and adherence to clinical guidelines. Read more at straitstimes.com. Read more at straitstimes.com.

Work pressure, late-night routines, irregular meals, and obesity are now key contributors to the rising prevalence of ...

The India Clindamycin HCL market presents opportunities due to high bacterial infection rates, increasing demand for ...

The passage of SB1124 serves as a stark reminder to every state that the quality of provider education cannot be taken for granted.

Pharos Capital Group, LLC ("Pharos"), a private healthcare investment firm focused on underserved communities, announced today that its portfolio company THEMA Health Services ("THEMA" or "the Company ...